HC Wainwright & Co. Reiterates Buy on Evotec, Maintains $11 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Douglas Tsao has reiterated a Buy rating on Evotec (NASDAQ:EVO) and maintained the price target at $11.
May 23, 2024 | 11:17 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Douglas Tsao has reiterated a Buy rating on Evotec and maintained the price target at $11.
The reiteration of a Buy rating and the maintenance of the price target at $11 by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100